Diagnosing secondary hypertension

American Family Physician

Volumn 67, Issue 1, 2003, Pages 67-74

  Onusko, Edward ^a  

^a Clinton Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE MESILATE; CATECHOLAMINE; CELECOXIB; CORTICOSTEROID; CREATININE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; CYCLOSPORIN A; ERYTHROPOIETIN; ESTROGEN; FLUDROCORTISONE; GLUCOSE; IBUPROFEN; IMMUNOSUPPRESSIVE AGENT; LIPID; METHAMPHETAMINE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PHENELZINE; PIROXICAM; POTASSIUM; PSEUDOEPHEDRINE; ROFECOXIB; SIBUTRAMINE; SODIUM; TACROLIMUS; TESTOSTERONE; UNINDEXED DRUG; VALDECOXIB;

ALCOHOL ABUSE; AORTA COARCTATION; ARTICLE; BLOOD CELL COUNT; BLOOD CHEMISTRY; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CREATININE BLOOD LEVEL; CUSHING DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIET; DISEASE EXACERBATION; ELECTROCARDIOGRAM; ENDOCRINE DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY PARENCHYMA; LABORATORY TEST; LIPID BLOOD LEVEL; PATHOGENESIS; POTASSIUM BLOOD LEVEL; SLEEP APNEA SYNDROME; SODIUM BLOOD LEVEL; URINALYSIS;

BLOOD PRESSURE DETERMINATION; CRITICAL PATHWAYS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TESTS, ROUTINE; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 0037286980     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. O'Rorke JE, Richardson WS. Evidence based management of hypertension: what to do when blood pressure is difficult to control. BMJ 2001;322:1229-32.
2. Wofford MR, King DS, Wyatt SB, Jones DW. Secondary hypertension: detection and management for the primary care provider. J Clin Hypertens 2000;2:124-31.
3. Setaro JF. An update on the diagnostic evaluation of the hypertensive patient. J Clin Hypertens 2000;2:25-32.
4. Oparil S, Calhoun DA. Managing the patient with hard-to-control hypertension. Am Fam Physician 1998;57:1007-14.
5. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
6. Silverberg DS, Oksenberg A. Essential and secondary hypertension and sleep-disordered breathing: a unifying hypothesis. J Hum Hypertens 1996;10:353-63.
7. Kaplan NM. Other forms of secondary hypertension. In: Kaplan NM, Lieberman E, eds. Clinical hypertension. 7th ed. Baltimore: Williams & Wilkins, 1998:395-406.
8. Stradling JR, Partlett J, Davies RJ, Siegwart D, Tarassenko L. Effect of short term graded withdrawal of nasal continuous positive airway pressure on systemic blood pressure in patients with obstructive sleep apnea. Blood Press 1996;5:234-40.
9. Victor LD. Obstructive sleep apnea. Am Fam Physician 1999;60:2279-86.
10. Gordon RD. Mineralocorticoid hypertension. Lancet 1994;344:240-3.
11. Ganguly A. Primary aldosteronism. N Engl J Med 1998;339:1828-34.
12. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994;21:315-8.
13. Kaplan NM. Renal vascular hypertension. In: Kaplan NM, Lieberman E, eds. Clinical hypertension. 7th ed. Baltimore: Williams & Wilkins, 1998:301-21.
14. Pohl M. Renal artery stenosis, renal vascular hypertension, and ischemic nephropathy. In: Schrier RW, Gottschalk CW, eds. Diseases of the kidney. 6th ed. Boston: Little, Brown, 1997:1367-423.
15. Cohen DL, Townsend RR. How to manage complex hypertension. Emerg Med 2001;33:20-9.
16. Yucel EK. MRA of the aorta, visceral and peripheral arteries. In: Higgins CB, Hricak H, Helms CA, eds. Magnetic resonance imaging of the body. 3d ed. Philadelphia: Lippincott-Raven, 1997:1383-99.
17. Aitchison F, Page A. Diagnostic imaging of renal artery stenosis. J Hum Hypertens 1999;13:595-603.
18. Kaplan NM. Renal parenchymal hypertension. In: Kaplan NM, Lieberman E, eds. Clinical hypertension. 7th ed. Baltimore: Williams & Wilkins, 1998:281-99.
19. Phenylpropanolamine and other OTC alpha-adrenergic agonists. Med Lett Drugs Ther 2000;42:113.
20. Morelli V, Zoorob RJ. Alternative therapies: part I. Depression, diabetes, obesity. Am Fam Physician 2000;62:1051-60.
21. Perloff JK. Congenital heart disease in adults. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia: Saunders, 1997:963-87.
22. Steiner RM. Radiology of the heart. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. 5th ed. Philadelphia: Saunders, 1997:204-39.
23. Fitzgerald PA. Endocrinology. In: Tierney LM, ed. Current medical diagnosis and treatment, 2001. 40th ed. New York: Lange/McGraw-Hill, 2001: 1088-160.
24. Oral contraception. In: Speroff L, Glass RH, Kase NG, eds. Clinical gynecologic endocrinology and infertility. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 1999:867-945.
25. Menopause and the perimenopausal transition. In: Speroff L, Glass RH, Kase NG, eds. Clinical gynecologic endocrinology and infertility. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 1999:643-724.
26. Kaplan, NM. Treatment of hypertension: nondrug therapy. In: Kaplan NM, Lieberman E, eds. Clinical hypertension. 7th ed. Baltimore: Williams & Wilkins, 1998:323-44.
27. Basic metabolism and physiologic effects of the methylxanthines. In: Spiller GA, ed. Caffeine. Boca Raton, Fla.: CRC Press, 1998:225-31.
28. Alexander D. Obesity and coronary heart disease. In: Alpert MA, Alexander JK, eds. The heart and lung in obesity. Armonk, N.Y.: Futura, 1998:213-38.
29. Dluhy RG, Williams RH. Endocrine hypertension. In: Williams RH, Wilson JD, eds. Williams Textbook of endocrinology. 9th ed. Philadelphia: Saunders, 1998:729-49.
30. Williams GH. Approach to the patient with hypertension. In: Braunwald E, ed. Harrison's Principles of internal medicine. 15th ed. New York: McGraw-Hill, 2001:211-4.
31. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002;187:1427-34.
32. Health care guideline: Hypertension diagnosis and treatment. Retrieved November 2002, from www.icsi.org/guide/HTN.pdf.
33. Krijnen P, van Jaarsveld BC, Steyerberg EW, Man in 't Veld AJ, Schalekamp MA, Habbema JD. A clinical prediction rule for renal artery stenosis. Ann Intern Med 1998;129:705-11.
34. Hall WD. A rational approach to the treatment of hypertension in special populations. Am Fam Physician 1999;60:156-62.
35. Oparil S. Arterial hypertension. In: Cecil RL, Goldman L, Bennett JC, eds. Cecil Textbook of medicine. 21st ed. Philadelphia: Saunders, 2000:258-73.
36. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.